financetom
Business
financetom
/
Business
/
Battle Over Beds: FTC Sues To Block Tempur Sealy's $4B Bid for Mattress Firm, Citing Competition Concerns
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Battle Over Beds: FTC Sues To Block Tempur Sealy's $4B Bid for Mattress Firm, Citing Competition Concerns
Jul 3, 2024 4:04 AM

Tempur Sealy International, Inc. ( TPX ) faces a roadblock as the Federal Trade Commission (FTC) voted unanimously to block its proposed $4 billion acquisition of Mattress Firm Group Inc.

The merger, which would combine the world’s largest mattress manufacturer with the nation’s largest mattress retailer, has raised significant competition concerns, per the regulator.

The FTC issued an administrative complaint and filed a lawsuit to halt the acquisition, alleging that Tempur Sealy’s acquisition of Mattress Firm would suppress competition and raise prices for millions of consumers.

The merger would grant the combined company enormous control over the mattress supply chain, integrating manufacturing with retail operations.

The FTC claims that Tempur Sealy ( TPX ) plans to limit competitors’ access to Mattress Firm’s network, potentially harming American mattress manufacturers, leading to reduced output, factory closures, and job losses.

“This deal isn’t about creating efficiencies; it’s about crippling the competition, which would raise prices on an essential good and could lead to layoffs for good paying American manufacturing jobs in nearly a dozen states,” said Henry Liu, Director of the FTC’s Bureau of Competition.

Mattress Firm, with its vast retail footprint, is crucial for mattress suppliers like Serta Simmons Bedding and Purple Innovation Inc ( PRPL ). .

The acquisition could allow Tempur Sealy ( TPX ) to dominate the premium mattress market by restricting rivals’ access to retail channels, leading to higher prices and reduced product quality.

The FTC alleges that the merger could result in Tempur Sealy ( TPX ) limiting rivals’ access to Mattress Firm’s stores and prioritizing its products.

The majority of mattresses sold in the U.S. are manufactured domestically, with sales reaching $7.8 billion last year, compared to $809 million in imports, according to the International Sleep Products Association, reported Reuters.

To address regulatory concerns, Tempur Sealy ( TPX ) has suggested divesting some stores and maintaining agreements with other mattress manufacturers.

However, the FTC remains firm on its stance against the merger, emphasizing the potential harm to competition and consumer choice.

Earlier today, Tempur Sealy ( TPX ) issued a statement that will hold a conference call on Monday, July 8th, to discuss its response to the filing of FTC complaint. The company said its commentary will be limited as the acquisition is being challenged in court. 

Price Action: TPX shares closed higher by 2.35% at $48.32 on Tuesday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved